Covered recipient · General Payments record
KELLI MCCALL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$479.53
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $332.51 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $74.34 | 4 |
| Lilly USA, LLC | $61.48 | 3 |
| MDD US Operations, LLC | $41.36 | 2 |
| Amgen Inc. | $31.73 | 2 |
| Acerta Pharma LLC | $27.66 | 1 |
| Lundbeck LLC | $25.58 | 1 |
| ACADIA Pharmaceuticals Inc | $24.08 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.10 | 1 |
| UCB, Inc. | $16.10 | 1 |
| Janssen Biotech, Inc. | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.26 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107616924 | CMS |
| ABBVIE INC. | $17.83 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107616926 | CMS |
| ABBVIE INC. | $13.78 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107616928 | CMS |
| ABBVIE INC. | $26.47 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107616930 | CMS |
| ACADIA Pharmaceuticals Inc | $24.08 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148009169 | CMS |
| Alexion Pharmaceuticals, Inc. | $17.10 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093912388 | CMS |
| Amgen Inc. | $13.33 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117322222 | CMS |
| Amgen Inc. | $18.40 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117322220 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.66 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105713438 | CMS |
| Janssen Biotech, Inc. | $13.08 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078735257 | CMS |
| Lilly USA, LLC | $23.83 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135774374 | CMS |
| Lilly USA, LLC | $16.78 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135774376 | CMS |
| Lilly USA, LLC | $20.87 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135735783 | CMS |
| Lundbeck LLC | $25.58 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146058045 | CMS |
| MDD US Operations, LLC | $20.30 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147756390 | CMS |
| MDD US Operations, LLC | $21.06 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147756392 | CMS |
| UCB, Inc. | $16.10 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143020921 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.